Mission Cure Inc.

“Form 990 Part III, Line 4 - Program Services 1. Developing therapies a. Advocated with more than 6 life sciences companies to pursue therapies for pancreatitis; provided information to support drug development b. Supported launch of Johns Hopkins Pancreatitis Pain Research Program, conducting research to identify the most effective treatments for pancreatitis patients' pain c. Worked with UK-based biotech Healx to understand chronic pancreatitis and identify and test therapeutic compounds d. Conducted inventory of animal models of pancreatitis and validated measures for outcomes important to patients 2.Engaging communities a. Reached over 39,000 patients, caregivers, clinicians, and scientists with website and over 5,000 people with educational videos b. Translated entire website into Spanish, including patient education materials c. Developed and disseminated new educational content about nutrition, pain management, and the patient experience 3. Improving care a. Collaborated with Johns Hopkins University to launch Johns Hopkins Pancreatitis Pain Research Program to effectively treat pancreatitis pain. b. Surveyed patients in partnership with two academic medical centers to determine symptoms and conditions that co-occur with chronic pancreatitis and may be related c. Completed "Best Practices" for pancreatitis care, reviewed by experts d. Developed a model for a virtual center of excellence that provides outcome-based, coordinated care FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION PROVIDES A DRAFT COPY OF FORM 990 FOR THE BOARD TO REVIEW PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C Mission: Cure is committed to avoiding conflicts of interests or the appearance of such conflicts that may call into question the integrity of the organization and its work. There are two primary situations that give rise to conflicts or the appearance of conflicts: when Mission: Cure employees have relationships with parties that do business with Mission: Cure (and in particular, when they give or accept gifts from such parties), and when Mission: Cure employees participate in outside activities that relate to, draw upon or compete with the work of Mission: Cure. In addition, certain contracts have prohibitions on the parties with whom you may do business. Conflict of interest situations are often complex, and you must consult Executive Director before engaging in such activity. FORM 990, PART VI, SECTION B, LINE 13: Mission: Cure will investigate any suspected fraudulent or dishonest use or misuse of Mission: Cure's resources or property by staff, board members, consultants or volunteers. Mission: Cure is committed to maintaining the highest standards of conduct and ethical behavior and promotes a working environment that values respect, fairness and integrity. All staff, board members and volunteers shall act with honesty, integrity and openness in all their dealings as representatives for the organization and comply with all applicable laws and regulations. Failure to follow these standards will result in disciplinary action including possible termination of employment, dismissal from one's board or volunteer duties and possible civil or criminal prosecution if warranted. FORM 990, PART VI, SECTION B, LINE 15: COMPENSATION PROCESS FOR TOP OFFICIAL: THE ORGANIZATION USES THE DEPARTMENT OF LABOR STATISTICS AND SALARY GUIDE TO OBTAIN COMPARABLE DATA ON POSITIONS. FURTHERMORE, THE ORGANIZATION PERIODICALLY REVIEW THE COMPENSATION ARRANGEMENTS AND BENEFITS TO ENSURE THAT THEY ARE REASONABLE, BASED ON COMPETENT SURVEY INFORMATION AND THE RESULT OF ARM'S LENGTH BARGAINING. FORM 990, PART IV, SECTION C, LINE 19B GOVERNING DOCUMENTS, DISCLOSURE EXPLANATION, THE FINANCIAL STATEMENTS, AND OTHER DOCUMENTS, SUCH AS THE CONFLICT OF INTEREST POLICY AND GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST.”

“Description:other fees total fees:46491”